论文部分内容阅读
目的分析呋塞米(速尿)结合硫酸镁雾化吸入对支气管哮喘患儿的临床效果。方法 50例支气管哮喘患儿,依据随机数字表法分为研究组与对照组,每组25例。对照组患儿应用常规药物进行治疗,研究组患儿采取速尿结合硫酸镁雾化吸入治疗。对比两组患儿临床治疗效果。结果治疗后,对照组总有效率68.0%低于研究组92.0%,差异具有统计学意义(P<0.05)。研究组患儿治疗后发热、喘息、肺部啰音消失时间以及住院时间[(3.20±1.63)h、(4.28±0.26)h、(3.01±1.06)d、(5.28±0.22)d]均显著短于对照组[(5.30±1.33)h、(6.35±1.51)h、(5.43±1.03)d、(8.35±1.33)d],差异具有统计学意义(P<0.05)。结论应用速尿结合硫酸镁雾化吸入治疗支气管哮喘患儿,可以使患儿病情明显好转,较常规西医药物治疗具有更好的疗效,提高临床治疗效果,值得临床推广。
Objective To analyze the clinical effect of furosemide (furosemide) combined with magnesium sulfate atomization inhalation on children with bronchial asthma. Methods Fifty children with bronchial asthma were divided into study group and control group according to random number table method, with 25 cases in each group. The control group of children with conventional drugs for treatment, the study group to take furosemide with magnesium sulfate atomization inhalation therapy. The clinical effects of two groups were compared. Results After treatment, the total effective rate of the control group was 68.0% lower than that of the study group (92.0%), the difference was statistically significant (P <0.05). The incidence of fever, wheezing, disappearance of pulmonary rales and hospital stay [(3.20 ± 1.63) h, (4.28 ± 0.26) h, (3.01 ± 1.06) d, (5.28 ± 0.22) d] were significantly higher in the study group than those in the study group (5.30 ± 1.33) h, (6.35 ± 1.51) h, (5.43 ± 1.03) d and (8.35 ± 1.33) d, respectively. The difference was statistically significant (P <0.05). Conclusions The application of furosemide and atomized magnesium sulfate inhalation to treating children with bronchial asthma can make the condition of children improve obviously, have better curative effect than conventional western medicine and improve clinical curative effect, which is worthy of clinical promotion.